Jiangsu, China

Jiaxin Song

This inventor holds 1 USPTO granted patent. Top assignees: Changzhou Syntheall Pharmaceuticals Co., Ltd., Shanghai Sta Pharmaceutical R&d Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiaxin Song. Retrieved from https://idiyas.com/inventor/jiaxin-song-arr2egko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiaxin Song: Innovator in Pharmaceutical Compositions

Introduction

Jiaxin Song is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compositions and processes.

Latest Patents

Jiaxin Song holds a patent for "Compositions comprising dichloroacetic acid, processes for preparing same and uses thereof." This patent discloses a composition that includes dichloroacetic acid and outlines a process for its preparation. Notably, it has been discovered that a novel impurity, glyoxylic acid, can be detected and accurately measured in dichloroacetic acid using ion chromatography methods. He has 1 patent to his name.

Career Highlights

Throughout his career, Jiaxin has worked with prominent companies in the pharmaceutical industry. He has been associated with Changzhou Syntheall Pharmaceuticals Co., Ltd. and Shanghai Sta Pharmaceutical R&D Co., Ltd. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Jiaxin has collaborated with several professionals in his field, including Hu Cheng and Chenchen Hu. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Jiaxin Song is a distinguished inventor whose work in pharmaceutical compositions has made a significant impact. His innovative approaches and collaborations continue to advance the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…